Results 51 to 60 of about 1,041,462 (205)

Determinants of Early Renal Function Recovery After TIPS in Patients With Portal Hypertension

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Renal dysfunction frequently occurs in patients with portal hypertension and is linked to unfavorable clinical outcomes. Transjugular intrahepatic portosystemic shunt (TIPS) has the potential to enhance renal perfusion through portal decompression; however, factors predicting early improvement in renal function remain insufficiently defined ...
Meng Jia, Yang Luo, Zhao‐Yang Tan, Xiao‐Ling Zhou, Xi‐You Zhang, Jing‐Ying Sun, Ye Du   +6 more
wiley   +1 more source

COMPARISON OF EFFICACY ON NORADRENALINE AND TERLIPRESSIN IN HEPATORENAL SYNDROME IN THE PATIENTS OF DECOMPENSATED CIRRHOSIS – A RANDOMIZED CONTROLLED STUDY

Pakistan Armed Forces Medical Journal, 2019
Objective: To compare the efficacy of noradrenaline and terlipressin in hepatorenal syndrome. Study Design: Randomized controlled trial. Place and Duration of Study: Combined Military Hospital Lahore, from May 2018 to Jan 2019.
Muhammad Siddique, Mansoor Ud Din Sajid, Omar Ahsan   +2 more
doaj   +4 more sources

Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)

Gastroenterologìa
Hepatorenal syndrome is a critical and potentially life-threatening complication in patients with advanced liver cirrhosis, characterized by the development of renal dysfunction in the absence of underlying structural kidney disease.
M.I. Tutchenko, D.V. Rudyk, M.S. Besedinskyi, S.L. Chub, Yu.V. Nerushchenko   +4 more
doaj   +1 more source

Do old urinary biomarkers have a place in the new definition of hepatorenal syndrome in the Egyptian cirrhotic patients? A single-center experience

Egyptian Liver Journal, 2022
Background Hepatorenal syndrome is still a diagnosis of exclusion despite new classification. Aims To validate the accuracy of urinary neutrophil gelatinase-associated lipocalin, interleukin-18, and kidney injury molecule-1 in the new diagnostic criteria
Mona Abd El-Rahman Abu El-Makarem, Yehia Zakaryia Mahmoud, Mahmoud Mohammed Moussa, Shereen Mohammed Mohammed El-Saghir, Hesham Kamal Habeeb Keryakos   +4 more
doaj   +1 more source

Microbubble‐Based Ultrasound Contrast Agents in Contrast‐Enhanced Ultrasonography for Managing Portal Hypertension in Cirrhosis

Portal Hypertension &Cirrhosis, EarlyView.
As the hepatic venous pressure gradient (HVPG) remains the current gold standard for diagnosing portal hypertension in cirrhosis, its clinical application is limited by invasiveness, high cost, and restricted availability. Given the urgent need for noninvasive techniques to dynamically monitor portal vein pressure (PVP), contrast‐enhanced ...
Danping Huang, Zefeng Liu, Lingling Liu, Fen Huang, Wenjuan Wang, Guo Zhang   +5 more
wiley   +1 more source

Circulatory function and hepatorenal syndrome in cirrhosis

, 2005
The pathogenic mechanism of hepatorenal syndrome is not well established. We investigated the circulatory function in cirrhosis before and after the development of hepatorenal syndrome.
Monescillo Francia, Alberto Fernando, Ginés, Pere, Valer, Paz, Jiménez, Wladimiro, Arroyo, Vicente, Milicua, José María, Ruiz-del-Arbol, Luis, Arocena, Carlos, Moreira, Víctor   +8 more
core   +1 more source

Combined Liver-Kidney Transplantation for Hepatorenal Syndrome

International Journal of Organ Transplantation Medicine, 2015
Among various complications of end-stage liver disease, hepatorenal syndrome has the highest mortality. Patients with both end-stage liver disease and end-stage renal disease are candidates for combined liver-kidney transplantation.
V Kanubhai Sutariya, A Tank, P Ramanlal Modi   +2 more
doaj  

Syndrome Hépatorénal : Aspects Epidémiologiques, Diagnostiques et Pronostiques

Health Research in Africa
RÉSUMÉ Introduction. Le syndrome Hépatorénal (SHR) est une forme particulière d’insuffisance rénale aigue fonctionnelle qui survient chez le patient atteint de cirrhose décompensée. Le traitement curatif reste la transplantation hépatique.
Ousseini F, Bonkano D, Hamidine I, Abdou B, Nayama M, Ali cheik R, Abdou N, Abdou Djibo B, Lawagoulé Joseph Emile KY, Sani K, Daou M   +10 more
doaj   +1 more source

Diagnosis of Portal Hypertension: Advancing Towards Non‐Invasive Solutions

Portal Hypertension &Cirrhosis, EarlyView.
This review systematically summarizes a full spectrum of non‐invasive diagnostic approaches for portal hypertension (PH), including imaging modalities, elastography, serum biomarkers, composite scoring systems and endoscopic ultrasound‐guided portal pressure gradient (EUS‐PPG), and analyzes their performance across different liver disease etiologies ...
Lijia Yin, Huikuan Chu, Ling Yang
wiley   +1 more source

Recurrent and De Novo Cirrhosis After Liver Transplantation

Portal Hypertension &Cirrhosis, EarlyView.
Schematic illustrating the development of cirrhosis after liver transplantation for cirrhosis. Following transplantation of a healthy donor graft, cirrhosis may develop either through recurrence of the original liver disease (recurrent cirrhosis) or through development of a different liver disease in the transplanted graft (de novo cirrhosis). ABSTRACT
Abhinav K. Rao, Don C. Rockey
wiley   +1 more source